Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/02/2000 | WO2000031274A1 Genetically modified plants with altered starch |
06/02/2000 | WO2000031273A2 Process for oxidising terpenes |
06/02/2000 | WO2000031271A1 Hiv infection inhibitors |
06/02/2000 | WO2000031270A1 Bartonella proteins and uses thereof |
06/02/2000 | WO2000031269A2 Plant cell proliferation-associated proteins |
06/02/2000 | WO2000031268A1 Maize rad23 genes and uses thereof |
06/02/2000 | WO2000031267A1 Insulin production by engineered muscle cells |
06/02/2000 | WO2000031266A1 Human parathyroid hormone modifications, preparation and use |
06/02/2000 | WO2000031265A1 Urotensins ii of mammals and their uses |
06/02/2000 | WO2000031264A2 Testis-specific cystatin-like protein cystatin t |
06/02/2000 | WO2000031263A2 Gtpase associated proteins |
06/02/2000 | WO2000031262A2 Human neurotensin subtype 2 receptor |
06/02/2000 | WO2000031261A2 Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor |
06/02/2000 | WO2000031260A1 Testis specific glycoprotein zpep10 |
06/02/2000 | WO2000031259A1 Mammalian secretory protein zsig43 |
06/02/2000 | WO2000031258A2 Human orphan g protein-coupled receptors |
06/02/2000 | WO2000031257A1 Novel serine protease bssp6 |
06/02/2000 | WO2000031256A1 Novel gene encoding brain-specific membrane protein |
06/02/2000 | WO2000031255A1 Novel ubiquitin-like protein |
06/02/2000 | WO2000031254A2 Apoptosis-inducing factor |
06/02/2000 | WO2000031253A2 Mutation of the parkin gene, compositions, methods and uses |
06/02/2000 | WO2000031252A1 Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target |
06/02/2000 | WO2000031251A1 Control of post harvest gene expression in plants by the use of harvest-regulated gene promoters |
06/02/2000 | WO2000031250A1 Nucleic acid fragments, recombinant vector containing the same and method for promoting the expression of structural gene by using the same |
06/02/2000 | WO2000031249A1 Root-preferred promoters and their use |
06/02/2000 | WO2000031248A1 Humanized monoclonal antibodies |
06/02/2000 | WO2000031247A2 Recombinant methods and materials for producing epothilone and epothilone derivatives |
06/02/2000 | WO2000031246A2 Methods for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof |
06/02/2000 | WO2000031245A1 Creatine amidinohydrolase and process for producing the same |
06/02/2000 | WO2000031244A1 Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof |
06/02/2000 | WO2000031243A1 Novel serine protease bssp5 |
06/02/2000 | WO2000031242A2 Engineered cytotoxic ribonuclease |
06/02/2000 | WO2000031241A2 Polypeptides having choline oxidase activity and nucleic acids encoding same |
06/02/2000 | WO2000031240A1 Immortalized brain endothelial cells |
06/02/2000 | WO2000031238A2 Methods and reagents for increasing proliferative capacity and preventing replicative senescence |
06/02/2000 | WO2000031237A2 Method of cloning porcine animals |
06/02/2000 | WO2000031236A2 Vectors for gene mutagenesis and gene discovery by gene trapping |
06/02/2000 | WO2000031235A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
06/02/2000 | WO2000031142A2 Plant syr2 homologs |
06/02/2000 | WO2000031141A1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
06/02/2000 | WO2000031140A1 Inhibitor of metalocarboxypeptidases as fibrinolytic agent |
06/02/2000 | WO2000031137A1 Amino-terminal modified parathyroid hormone (pth) analogs |
06/02/2000 | WO2000031133A2 Potassium channel interactors and uses therefor |
06/02/2000 | WO2000031132A1 Novel polypeptide |
06/02/2000 | WO2000031127A2 Protein fragments for use in protein targeting |
06/02/2000 | WO2000031126A2 Suppression of xenotransplant rejection |
06/02/2000 | WO2000031125A2 REGULATORY PROTEIN pKe#83 FROM HUMAN KERATINOCYTES |
06/02/2000 | WO2000031115A1 Methods of identifying antigen gene sequences |
06/02/2000 | WO2000031113A1 INTRACELLULAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
06/02/2000 | WO2000031111A1 Antisense modulation of nf-kappa-b p65 subunit expression |
06/02/2000 | WO2000031110A1 Identification of disease predictive nucleic acids |
06/02/2000 | WO2000031108A1 Dna molecules encoding hg51, a g-protein-coupled receptor |
06/02/2000 | WO2000031106A1 Antisense modulation of mek1 expression |
06/02/2000 | WO2000031105A1 Antisense modulation of inhibitor-kappa b kinase-beta expression |
06/02/2000 | WO2000031103A1 Antisense modulation of mek2 expression |
06/02/2000 | WO2000031101A1 Method for the electrochemical detection of nucleic acid oligomer hybrids |
06/02/2000 | WO2000031022A1 Amphiphilic polyamine compounds |
06/02/2000 | WO2000030687A1 Novel adenoviral vector and methods for making and using the same |
06/02/2000 | WO2000030686A1 Antisense modulation of inhibitor-kappa b kinase-alpha expression |
06/02/2000 | WO2000030680A1 Tumor antigen-specific antibody-gp39 chimeric protein constructs |
06/02/2000 | WO2000030673A1 Uses for eph receptor antagonists and agonists to treat vascular disorders |
06/02/2000 | WO2000030671A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
06/02/2000 | WO2000030667A2 Compositions and methods using lactadherin or variants thereof |
06/02/2000 | WO2000030662A1 Fabz |
06/02/2000 | WO2000030590A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
06/02/2000 | WO2000030587A2 NF-λB ACTIVATION INHIBITORS, AND THEIR PHARMACEUTICAL USES |
06/02/2000 | WO2000030441A1 Cryopreservation of oocytes and embryos and methods for producing animals involving the same |
06/02/2000 | WO2000030437A1 Transgenic animals |
06/02/2000 | WO2000030436A1 Stabilisation of milk from transgenic animals |
06/02/2000 | WO2000016061A3 Method for diagnosing the active stage of a cytomegalovirus infection in human substrates |
06/02/2000 | WO2000014545A9 Multihued labels |
06/02/2000 | WO2000014244A3 Treatment of cervical cancer |
06/02/2000 | WO2000014236A3 Grf analogs with increased biological potency |
06/02/2000 | WO2000013703A9 Methods of treating hypertension and compositions for use therein |
06/02/2000 | WO2000012725A3 Transgenic amorpha-4,11-diene synthesis |
06/02/2000 | WO2000012716A3 MAIZE Ku70 ORTHOLOGUE AND USES THEREOF |
06/02/2000 | WO2000011192A3 Plant glutamine: fructose-6-phosphate amidotransferase nucleic acids |
06/02/2000 | WO2000011185A3 Improved expression of cry3b insecticidal protein in plants |
06/02/2000 | WO2000011178A3 An antifungal protein from tall fescue and its use in plant disease control |
06/02/2000 | WO2000011148A9 Cold-shock regulatory elements, constructs thereof, and methods of use |
06/02/2000 | WO2000009715A9 Modulation of polypeptide display on modified filamentous phage |
06/02/2000 | WO2000008213A9 Oligomers which inhibit expression of collagen genes |
06/02/2000 | WO2000008177A3 Death associated kinase containing ankyrin repeats (dakar) |
06/02/2000 | WO2000008131A3 Pseudotyped retroviruses and stable cell lines for their production |
06/02/2000 | WO2000008045A3 Novel molecules of the tango-93-related protein family and uses thereof |
06/02/2000 | WO2000005389A3 Production of proteins |
06/02/2000 | WO2000003024A9 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
06/02/2000 | WO1999067398A9 Overexpression of phytase genes in yeast systems |
06/02/2000 | WO1999066075A3 Diagnostic method based on quantification of extramitochondrial dna |
06/02/2000 | WO1999064594A8 Genes and gene expression products that are differentially regulated in prostate cancer |
06/02/2000 | WO1999063095A9 Nucleic acid vaccines for prevention of flavivirus infection |
06/02/2000 | WO1999062942A3 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
06/02/2000 | WO1999054446A3 Human nucleic acid sequences which are overexpressed in normal pancreas tissue |
06/02/2000 | CA2645717A1 Human orphan g protein-coupled receptors |
06/02/2000 | CA2369706A1 Testis specific glycoprotein zpep10 |
06/02/2000 | CA2364669A1 Testis-specific cystatin-like protein cystatin t |
06/02/2000 | CA2352606A1 Urotensins ii of mammals and their uses |
06/02/2000 | CA2352600A1 Inhibitor of metalocarboxypeptidases as fibrinolytic agent |
06/02/2000 | CA2352599A1 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
06/02/2000 | CA2352560A1 Mammalian secretory protein zsig43 |